semaglutide gut health Windmill Response GLP-1 Support Capsules for Digestive Health, Metabolic Support, and Daily Wellness, 30 Count GLP-1 and Gut Health: Addressing

Semaglutide is contraindicated in patients with: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Common Adverse Effects According to clinical trial data, gastrointestinal effects are most frequently reported: nausea, vomiting, diarrhea, constipation, and abdominal discomfort

It is unclear whether the effects on weight are sufficient, by themselves, to enable fibrosis regression

It was a pre-approval cardiac safety assessment trial with a primary objective of non-inferiority to placebo, which was basically done to get early approval as per regulatory guidance

Your GP can provide referrals to appropriate NHS services and ensure any treatment approach is safe and evidence-based

The clinical event reduction documented in the SELECT trial (20 percent reduction in MACE) reflects these early changes sustained over years